Komaraiah Palle

6PUBLICATIONS
12CO-AUTHORS
Cancer diagnosisCancer therapy (excl. chemotherapy and radiation therapy)Molecular medicineGenome structure and regulationMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|May 15, 2025
Evaluating Efficacy of Cervical HPV-HR DNA Testing as Alternative to PET/CT Imaging for Posttreatment Cancer Surveillance: Retrospective Proof-of-Concept Study.

Cameron Huddleston, Chinnadurai Mani, Naresh Sah

|Jun 11, 2024
CHK1 inhibitor induced PARylation by targeting PARG causes excessive replication and metabolic stress and overcomes chemoresistance in ovarian cancer.

Ganesh Acharya, Chinnadurai Mani, Naresh Sah

|Feb 17, 2021
AraC-FdUMP[10] Is a Next-Generation Fluoropyrimidine with Potent Antitumor Activity in PDAC and Synergy with PARG Inhibition.

Alex O Haber, Aditi Jain, Chinnadurai Mani

|Dec 28, 2020
Improved Antitumor Activity of the Fluoropyrimidine Polymer CF10 in Preclinical Colorectal Cancer Models through Distinct Mechanistic and Pharmacologic Properties.

William H Gmeiner, Anthony Dominijanni, Alex O Haber

|Jan 29, 2020
The multifunctional protein PACS-1 is required for HDAC2- and HDAC3-dependent chromatin maturation and genomic stability.

Chinnadurai Mani, Kaushlendra Tripathi, Shan Luan

|Sep 08, 2019
Prexasertib treatment induces homologous recombination deficiency and synergizes with olaparib in triple-negative breast cancer cells.

Chinnadurai Mani, Shirisha Jonnalagadda, Jojireddy Lingareddy

Pageof 1

Frequent Collaborators

2 joint publications

Mark B Reedy

1 joint publications

Anthony Dominijanni

1 joint publications

Boris C Pasche

1 joint publications

Sezgin Kiren